Authors: TYRRELL CJ DENIS L NEWLING D SOLOWAY M CHANNER K COCKSHOTT ID

Citation: Cj. Tyrrell et al., CASODEX(TM) 10-200 MG DAILY, USED AS MONOTHERAPY FOR THE TREATMENT OFPATIENTS WITH ADVANCED PROSTATE-CANCER - AN OVERVIEW OF THE EFFICACY,TOLERABILITY AND PHARMACOKINETICS FROM 3-PHASE-II DOSE-RANGING STUDIES, European urology, 33(1), 1998, pp. 39-53

Authors: BLACKLEDGE GRP COCKSHOTT ID FURR BJA

Citation: Grp. Blackledge et al., CASODEX(TM) (BICALUTAMIDE) - OVERVIEW OF A NEW ANTIANDROGEN DEVELOPEDFOR THE TREATMENT OF PROSTATE-CANCER, European urology, 31, 1997, pp. 30-39

Authors: COCKSHOTT ID OLIVER SD YOUNG JJ COOPER KJ JONES DC

Citation: Id. Cockshott et al., THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF THE BICALUTAMIDE (CASODEX) ENANTIOMERS, Biopharmaceutics & drug disposition, 18(6), 1997, pp. 499-507

Authors: MCKILLOP D SIMONS PJ COCKSHOTT ID HILL SJ HARDING JR COOPER KJ JONES DC

Citation: D. Mckillop et al., ENANTIOSELECTIVE METABOLISM AND PHARMACOKINETICS OF CASODEX IN THE MALE-RAT, Xenobiotica, 25(6), 1995, pp. 623-633

Authors: COCKSHOTT ID SOTANIEMI EA COOPER KJ JONES DC

Citation: Id. Cockshott et al., THE PHARMACOKINETICS OF CASODEX ENANTIOMERS IN SUBJECTS WITH IMPAIREDLIVER-FUNCTION, British journal of clinical pharmacology, 36(4), 1993, pp. 339-343

Authors: MCKILLOP D BOYLE GW COCKSHOTT ID JONES DC PHILLIPS PJ YATES RA

Citation: D. Mckillop et al., METABOLISM AND ENANTIOSELECTIVE PHARMACOKINETICS OF CASODEX IN MAN, Xenobiotica, 23(11), 1993, pp. 1241-1253